Skip to main content
. 2017 Aug 17;12(8):e0183306. doi: 10.1371/journal.pone.0183306

Fig 3. Mean cost–effectiveness under the baseline threshold value of € 73 444 (+/– 20%) of vaccination with Rotarix® (2–doses) and RotaTeq® (three–doses) at 94.7% coverage from a healthcare perspective, Norway, 2015–2019.

Fig 3